𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Imatinib mesylate effective in systemic mast cell disease

Book ID
120859913
Publisher
Adis International Limited (now part of Wolters Kluwer Health)
Year
2003
Weight
133 KB
Volume
&NA;
Category
Article
ISSN
1173-8324

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Imatinib for systemic mast-cell disease
Imatinib for systemic mast-cell disease
✍ A Pardanani; M Elliott; T Reeder; C-Y Li; EJ Baxter; NCP Cross; A Tefferi πŸ“‚ Article πŸ“… 2003 πŸ› The Lancet 🌐 English βš– 919 KB
Is imatinib mesylate a promising drug in
Is imatinib mesylate a promising drug in systemic sclerosis?
✍ P. L. A. van Daele; W. A. Dik; H. B. Thio; P. Th. W. van Hal; J. A. M. van Laar; πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 114 KB

## Abstract A patient with therapy‐resistant and progressive systemic sclerosis (SSc) with pulmonary involvement who was treated with imatinib mesylate is described herein. Prior to treatment, pulmonary fibroblasts obtained from the patient were cultured and incubated with imatinib mesylate. Preinc

Heparin effects in systemic mast cell di
Heparin effects in systemic mast cell disease
✍ Campbell W. McMillan; Harold J. Fallon; Robert Zeppa πŸ“‚ Article πŸ“… 1966 πŸ› Elsevier Science 🌐 English βš– 101 KB
Effects of imatinib mesylate in osteobla
Effects of imatinib mesylate in osteoblastogenesis
✍ Daniele Tibullo; Cesarina Giallongo; Piera La Cava; Salvatore Berretta; Fabio St πŸ“‚ Article πŸ“… 2009 πŸ› Elsevier Science 🌐 English βš– 560 KB